Roth Capital Upgrades Trinity Biotech (TRIB) to Buy
Tweet
Share
E-mailGet Alerts TRIB Hot Sheet
Price: $0.36 +2.86%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
Roth Capital upgraded Trinity Biotech (NASDAQ: TRIB) from Neutral to Buy with a price target of $30.00.
For an analyst ratings summary and ratings history on Trinity Biotecjh click here. For more ratings news on Trinity Biotecjh click here.
Shares of Trinity Biotecjh closed at $24.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market
- JPMorgan Upgrades HB Fuller (FUL) to Overweight
- Citi Upgrades Banco de Credito (BCI:CI) to Neutral
Create E-mail Alert Related Categories
UpgradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
